Advanced Code injection

Arsheen Kaur 8/16/23 Arsheen Kaur 8/16/23

OBIO® member companies among top ten Canadian tech firms to pitch innovative healthcare solutions

Read More

Arsheen Kaur 8/16/23 Arsheen Kaur 8/16/23

CryoStasis closes $8 million seed financing to develop next generation sub-zero unfrozen biopreservation for organ transplantation and cell/gene therapy products

Read More

Arsheen Kaur 8/15/23 Arsheen Kaur 8/15/23

Novo Nordisk to acquire Inversago Pharma to develop new therapies for people living with obesity and other serious metabolic diseases

Read More

Arsheen Kaur 8/14/23 Arsheen Kaur 8/14/23

FluidAI's artificial intelligence-powered post-surgical monitor, Stream™ Platform, launches globally

Read More

Arsheen Kaur 8/14/23 Arsheen Kaur 8/14/23

VoxNeuro raises $4.5 million CAD to scale brain performance software across U.S. clinics

Read More

Arsheen Kaur 7/31/23 Arsheen Kaur 7/31/23

Vive Crop Protection selected for inaugural cohort of Canada’s Global Hypergrowth Project

Read More

Arsheen Kaur 7/31/23 Arsheen Kaur 7/31/23

Vital Biosciences introduces revolutionary point-of-care lab testing platform & raises $48 million

Read More

Arsheen Kaur 7/31/23 Arsheen Kaur 7/31/23

Rostrum Medical announces the publication of initial validation results of its novel VQm® System

Read More

Arsheen Kaur 7/31/23 Arsheen Kaur 7/31/23

Retispec’s innovative AI technology transforming Alzheimer’s disease screening

Read More

Arsheen Kaur 7/31/23 Arsheen Kaur 7/31/23

ImmunoBiochem enters a deal with ImmunoGen to develop next-generation antibody-drug conjugates

Read More

Arsheen Kaur 7/18/23 Arsheen Kaur 7/18/23

SheBoot goes national to fuel the success of women entrepreneurs across Canada

Read More

Arsheen Kaur 7/17/23 Arsheen Kaur 7/17/23

BDC Thrive Lab launches $35m co-investment phase

Read More

Arsheen Kaur 7/17/23 Arsheen Kaur 7/17/23

VBI Vaccines and Brii Biosciences expand Hepatitis B partnership to address prevention and treatment

Read More

Arsheen Kaur 7/17/23 Arsheen Kaur 7/17/23

Epineuron announces launch of FDA clinical trial for bioelectronic therapy for nerve regeneration

Read More

Arsheen Kaur 7/17/23 Arsheen Kaur 7/17/23

Recursion announces collaboration and $50 million investment from NVIDIA

Read More

Arsheen Kaur 7/17/23 Arsheen Kaur 7/17/23

Ditch Labs secures $3.25 million to treat nicotine addiction with tech

Read More

Arsheen Kaur 7/4/23 Arsheen Kaur 7/4/23

Sunnybrook’s Medventions program expands to Atlantic Canada

Read More

Arsheen Kaur 7/4/23 Arsheen Kaur 7/4/23

Recursion opens its Canadian headquarters in Toronto

Read More

Arsheen Kaur 7/4/23 Arsheen Kaur 7/4/23

Oncoustics among Google’s first North America-wide cloud accelerator cohort

Read More

Arsheen Kaur 6/20/23 Arsheen Kaur 6/20/23

CABHI funds over $1.9 million in latest cohort of healthcare innovations for older adults and caregivers

Read More